Corpus Intelligence IC Memo — LAKE REGIONAL HEALTH SYSTEM 2026-04-26 04:03 UTC
IC Memo — LAKE REGIONAL HEALTH SYSTEM
Investment Committee Memorandum | MO | 105 beds | Grade C | EBITDA uplift $16.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LAKE REGIONAL HEALTH SYSTEM

CCN 260186 | CAMDEN, MO | 105 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LAKE REGIONAL HEALTH SYSTEM is a 105-bed suburban community hospital in CAMDEN, MO with $226.8M in net patient revenue and a -2.7% operating margin. The hospital serves a payer mix of 30.7% Medicare, 7.5% Medicaid, and 61.8% commercial.

Thesis: Undervalued. Our ML models identify $16.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.7% to 4.7% (+736bps).

Net Revenue HCRIS$226.8M
Current EBITDA COMPUTED$-6.0M
Operating Margin COMPUTED-2.7%
Occupancy HCRIS51.1%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS29.2%
Distress Probability ML47.4%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
38
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -2.7% places it above the state median. Among 38 size-comparable peers (52-210 beds), the median margin is 1.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (52-210), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LAKE REGIONAL HEALTH SYSTEM (Target)MO105$226.8M-2.7%
LIBERTY HOSPITALMO199$303.2M-3.1%
PHELPS COUNTY REGIONAL MEDICALMO196$270.3M33.1%
HANNIBAL REGIONAL HOSPITALMO86$226.2M-6.8%
SSM HEALTH ST CLARE HOSPITALMO180$225.5M2.8%
CAPITAL REGION MEDICAL CENTERMO100$224.0M-17.7%
BARNES JEWISH WEST COUNTY HOSPMO68$221.1M4.9%
COX MEDICAL CENTER BRANSONMO144$217.3M-0.8%
SSM HEALTH ST. JOSEPH HOSPITALMO179$208.4M1.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $16.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.8M+210bp18mo
Cost to Collect4.5%2.5%$4.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.8M+122bp9mo
Clean Claim Rate88.0%96.0%$145K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.8M
Cost to Collect
$4.5M
Denial Rate Reduction
$4.5M
A/R Days Reduction
$2.8M
Clean Claim Rate
$145K
Total EBITDA Uplift$16.7M
Current EBITDA$-6.0M
+ RCM Uplift+$16.7M
Pro Forma EBITDA$10.7M
Current Margin-2.7%
Pro Forma Margin4.7%
WC Released (1x)$8.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-9.3M$127.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-9.3M$136.9M0.00x-100.0%
Bull Case9.0x11.0x$-8.4M$189.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-8.4M$203.7M0.00x-100.0%
Bear Case11.0x10.0x$-10.2M$46.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-10.2M$48.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 52-210 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-9.2% / P50=1.0% / P75=13.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.